tracking the news, one byte at a time
Freak Pulse
Category: Health News
-
New Drug Trials and Approvals, Biogen’s Tau-Targeting Alzheimer’s Drug Shows Promise, and more.
New Drug Trials and Approvals this week: Biogen’s Phase 2 CELIA study of its tau-targeting antisense oligonucleotide diranersen (BIIB080) showed a clinically; and Biogen has announced topline results from the 18-month Phase 2 CELIA study…
-
Research, Treatment, and Policy, ADHD Medication Risks Realities Revealed Study, and more.
Research, Treatment, and Policy Developments this week: A 2026 Swedish cohort study in *BMJ Mental Health* finds adults with comorbid ADHD and substance use disorder (SUD); and This week’s research roundup highlights a tightening focus on…
-
Neurodiversity in the Workplace, ‘proudly autistic’ workplace expert, and more.
Neurodiversity in the Workplace: Accommodations and Employment this week: Workplace expert Dr.
-
Understanding and Diagnosing Autism, Reasons You Didn t Realize You re Autistic, and more.
Understanding and Diagnosing Autism, ADHD, and AuDHD this week: An article from the Autistic Self-Advocacy Network outlines systemic and social reasons why autistic adults; and A national survey commissioned by Ohio State University finds…
-
Roundup: FTD Treatment & Genetics, Black Box Warnings for Antipsychotics, and more.
Frontotemporal Signals this week: A clinical review outlines the severe limitations and risks of psychotropic medication for managing neuropsychiatric; and This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it…
-
A massive ADHD study reveals what actually works
Neurodiversity, ADHD, Autism, and AuDHD this week: A 2026 umbrella review synthesizing over 200 meta-analyses has established a clear hierarchy of evidence for ADHD; and The University of Exeter is leading a multinational, Horizon…
-
Research Reviews and Treatment Debates, 2026 Alzheimer’s disease facts figures – PMC, and more.
Research Reviews and Treatment Debates this week: The 2026 Alzheimer’s disease facts and figures report consolidates the state of early detection and treatment; and Harvard researchers Bruce Yankner, Sandeep Robert Datta, and Chenghua Gu…
-
Blood Tests and Biomarkers for Early, Alzheimer s 2026 Breakthrough, and more.
Blood Tests and Biomarkers for Early Detection this week: In 2026, Alzheimer’s disease management is being reshaped by the clinical deployment of high-precision blood; and Amsterdam UMC researchers have identified a novel cerebrospinal…
-
New Alzheimer’s Drug Trials and, Annovis Publishes Phase 2/3, and more.
New Alzheimer’s Drug Trials and Clinical Results this week: Annovis Bio has published peer-reviewed Phase 2/3 results for its oral Alzheimer’s candidate, buntanetap, in NPJ; and Annovis Bio has published peer-reviewed Phase 2/3 data for…
-
ASAN April Update
Neurodiversity, ADHD, Autism, and AuDHD this week: The Autistic Self Advocacy Network’s April update details a coordinated advocacy pushback against federal policy; and Diane J.